PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-30.55%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-46.45%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-97.89%
Negative EBIT growth while CX is at 4.52%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-97.89%
Negative operating income growth while CX is at 4.52%. Joel Greenblatt would press for urgent turnaround measures.
-88.18%
Negative net income growth while CX stands at 157.69%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-88.32%
Negative EPS growth while CX is at 156.67%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-88.32%
Negative diluted EPS growth while CX is at 156.67%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-3.85%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-3.06%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-135.43%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-181.94%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
9.79%
Positive 10Y revenue/share CAGR while CX is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
9.79%
5Y revenue/share CAGR under 50% of CX's 25.66%. Michael Burry would suspect a significant competitive gap or product weakness.
9.79%
3Y revenue/share CAGR under 50% of CX's 21.48%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-14.61%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-14.61%
Negative 5Y OCF/share CAGR while CX is at 89.01%. Joel Greenblatt would question the firm’s operational model or cost structure.
-14.61%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
547.47%
Net income/share CAGR above 1.5x CX's 175.01% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
547.47%
5Y net income/share CAGR similar to CX's 541.52%. Walter Schloss might see both on parallel mid-term trajectories.
547.47%
Positive short-term CAGR while CX is negative. John Neff would see a clear advantage in near-term profit trajectory.
4.46%
10Y equity/share CAGR above 1.5x CX's 0.01%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
4.46%
Below 50% of CX's 25.13%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
4.46%
Below 50% of CX's 35.64%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.46%
AR growth well above CX's 0.76%. Michael Burry fears inflated revenue or higher default risk in the near future.
7.64%
Inventory growth well above CX's 0.62%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.39%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-0.23%
We have a declining book value while CX shows 6.37%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
7.87%
We have some new debt while CX reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-12.59%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.